Home Supplements How We Rate Blog
Bacopa monnieri

Bacopa Monnieri

Research reviewed: Up until 03/2026

Bacopa Monnieri (Bacopa monnieri) is a dietary supplement with 15 published peer-reviewed studies involving 360 participants, researched for Memory Enhancement (Healthy Adults), Cognitive Function in the Elderly & Anxiety Reduction, Meta-Analyses & Systematic Reviews and 4 more areas.

15
Studies
360
Participants
2001–2025
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Strong Evidence

Memory Enhancement (Healthy Adults)

Moderate
2 studies 1 of 2 positive 84 participants

Cognitive Function in the Elderly & Anxiety Reduction

Moderate
3 studies 1 of 3 positive 94 participants

Meta-Analyses & Systematic Reviews

Weak
1 study 0 of 1 positive 9 participants 0 human

Memory & Cognition

Moderate
2 studies 1 of 2 positive 9 participants 1 human

ADHD & Attention

Moderate
1 study 1 of 1 positive 112 participants

Clinical trials

Moderate
3 studies 0 of 3 positive 52 participants

Systematic reviews

Weak
3 studies 0 of 3 positive 0 participants 0 human

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

11/15
Randomised
9/15
Double-Blind
10/15
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2001)
46
Study 2 (2002)
38
Study 1 (2008)
54
Study 2 (2008)
40
Study 3 (2012)
0
Study 1 (2014)
9
Study 1 (2013)
9
Study 2 (2023)
0

Research Timeline

When the studies were published

1
2001
1
2002
2
2008
1
2012
1
2013
1
2014
2
2022
3
2023
2
2024
1
2025

All Studies

Detailed breakdown of each trial. Click to expand.

Memory Enhancement (Healthy Adults)

1

To investigate effects of Bacopa Monnieri on verbal learning, memory consolidation, and information processing speed in healthy adults.

2001 46 participants 12 weeks (with assessments at 5 and 12 weeks) 300 mg/day (standardized extract, 55% bacosides)
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To investigate effects of Bacopa Monnieri on verbal learning, memory consolidation, and information processing speed in healthy adults.

Dose

300 mg/day (standardized extract, 55% bacosides)

Participants

46 healthy volunteers aged 18-60 years

Duration

12 weeks (with assessments at 5 and 12 weeks)

Results

Significant improvements in verbal learning, memory consolidation, and information processing speed compared to placebo. Effects were observed at both 5-week and 12-week timepoints, suggesting early and sustained cognitive benefit.

How They Measured It

Verbal learning, memory consolidation, information processing assessments

Read full study
2

To assess Bacopa Monnieri effects on memory performance and speed of attention in healthy middle-aged adults.

2002 38 participants 12 weeks 300 mg/day (standardized extract, 55% bacosides)
Human Study RCT Double-Blind Placebo Mixed

Study Type

Randomised, double-blind, placebo-controlled, crossover

Purpose

To assess Bacopa Monnieri effects on memory performance and speed of attention in healthy middle-aged adults.

Dose

300 mg/day (standardized extract, 55% bacosides)

Participants

38 healthy adults aged 40-64 years

Duration

12 weeks

Results

Improved speed of attention on the Stroop task and modest memory improvements. Effects persisted post-cessation, suggesting lasting neuroplastic changes rather than purely pharmacological effects.

How They Measured It

Stroop task reaction time, memory performance tests

Read full study

Cognitive Function in the Elderly & Anxiety Reduction

1

To evaluate Bacopa Monnieri effects on memory, cognitive performance, anxiety, and depression in healthy elderly adults.

2008 54 participants 12 weeks 300 mg/day (standardized extract, with 6-week placebo run-in...
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled, parallel-groups

Purpose

To evaluate Bacopa Monnieri effects on memory, cognitive performance, anxiety, and depression in healthy elderly adults.

Dose

300 mg/day (standardized extract, with 6-week placebo run-in)

Participants

54 healthy elderly adults (mean age 73.5 years), 48 completed

Duration

12 weeks

Results

Enhanced AVLT delayed word recall memory scores (p<0.05). Stroop performance improved. Depression and anxiety scores were significantly reduced. Heart rate decreased over time in the Bacopa group. These results suggest broad cognitive and mood benefits in older adults.

How They Measured It

AVLT (delayed recall), Stroop, State-Trait Anxiety Inventory, depression scale, heart rate

Read full study
2

To evaluate Bacopa Monnieri on attention, executive function, and working memory in healthy older adults.

2008 40 participants 12 weeks 300 mg/day
Human Study RCT Double-Blind Placebo Mixed

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate Bacopa Monnieri on attention, executive function, and working memory in healthy older adults.

Dose

300 mg/day

Participants

40 healthy older adults aged over 50 years

Duration

12 weeks

Results

Improved attention, executive function, and working memory scores compared to placebo. Modest but consistent improvements on MMSE. Supplement was well-tolerated with no adverse events reported.

How They Measured It

MMSE, attention, executive function, and working memory tests

Read full study
3

To evaluate effects of 12-week Bacopa monnieri consumption on attention, cognitive processing, working memory, and neurotransmitter function in healthy elderly

2012 ? participants 12 weeks Bacopa monnieri extract (standardized)
Human Study RCT Placebo Mixed

Study Type

Randomized, placebo-controlled trial

Purpose

To evaluate effects of 12-week Bacopa monnieri consumption on attention, cognitive processing, working memory, and neurotransmitter function in healthy elderly

Dose

Bacopa monnieri extract (standardized)

Participants

Healthy elderly volunteers

Duration

12 weeks

Results

Bacopa improved attention, cognitive processing speed, and working memory in elderly subjects. Cholinergic and monoaminergic system function enhanced

How They Measured It

Attention tests, cognitive processing speed, working memory tasks, neurotransmitter markers

Read full study

Meta-Analyses & Systematic Reviews

1

To quantify the cognitive-enhancing effects of Bacopa Monnieri across RCTs in healthy and cognitively impaired populations.

2014 9 participants 12+ weeks across included studies 300-600 mg/day (standardized extract)
Review/Other Mixed

Study Type

Systematic review & meta-analysis

Purpose

To quantify the cognitive-enhancing effects of Bacopa Monnieri across RCTs in healthy and cognitively impaired populations.

Dose

300-600 mg/day (standardized extract)

Participants

9 RCTs, 518 subjects; 437 eligible for meta-analysis

Duration

12+ weeks across included studies

Results

Meta-analysis showed improved cognition by shortened Trail B test (-17.9 ms, 95% CI -24.6 to -11.2, p<0.001) and decreased choice reaction time (-10.6 ms, 95% CI -12.1 to -9.2, p<0.001). The study confirms Bacopa Monnieri reliably improves speed of attention. Researchers noted larger head-to-head trials are still needed.

How They Measured It

Trail Making Test B, choice reaction time (CRT), cognitive composite outcomes

Read full study

Memory & Cognition

1

To evaluate cognitive effects of Bacopa monnieri extract

2013 9 participants Various study durations Bacopa monnieri extract (various doses)
Review/Other RCT Mixed

Study Type

Meta-analysis of randomized controlled trials

Purpose

To evaluate cognitive effects of Bacopa monnieri extract

Dose

Bacopa monnieri extract (various doses)

Participants

Meta-analysis of 9 studies with 518 subjects

Duration

Various study durations

Results

Bacopa monnieri improved cognition, particularly speed of attention. Meta-analysis of 437 eligible subjects showed improved cognition by shortened Trail B test and decreased choice reaction time.

How They Measured It

Cognitive function tests, memory assessments

Read full study
2

To assess effects of Bacopa monnieri on cognitive function, stress, and fatigue in healthy adults

2023 ? participants 8-12 weeks Bacumen® Bacopa monnieri extract
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled trial

Purpose

To assess effects of Bacopa monnieri on cognitive function, stress, and fatigue in healthy adults

Dose

Bacumen® Bacopa monnieri extract

Participants

Healthy adults

Duration

8-12 weeks

Results

Bacopa monnieri significantly improved cognitive function and reduced stress and fatigue markers compared to placebo.

How They Measured It

Cognitive function tests, stress markers, fatigue scales

Read full study

ADHD & Attention

1

To investigate effects of Bacopa monnieri on hyperactivity and inattention in male children and adolescents (BACHI Study)

2022 112 participants 6-8 weeks CDRI 08 Bacopa monnieri extract
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled trial

Purpose

To investigate effects of Bacopa monnieri on hyperactivity and inattention in male children and adolescents (BACHI Study)

Dose

CDRI 08 Bacopa monnieri extract

Participants

112 males aged 6-14 years with symptoms of inattention and hyperactivity

Duration

6-8 weeks

Results

Significant improvements in inattention, hyperactivity, and cognitive function in Bacopa group compared with placebo.

How They Measured It

ADHD symptoms, attention, hyperactivity scales

Read full study

Clinical trials

1

To investigate the effects of Bacopa Monnieri in neurocognitive effects a combined polyphenolic-rich herbal extract in healthy middle-aged adults - a randomised, double-blind, placebo-controlled stud

2024 52 participants 28 days Bacopa Monnieri (dose not specified)
Human Study RCT Double-Blind Placebo Mixed

Study Type

Randomized, double-blind, placebo-controlled

Purpose

To investigate the effects of Bacopa Monnieri in neurocognitive effects a combined polyphenolic-rich herbal extract in healthy middle-aged adults - a randomised, double-blind, placebo-controlled stud

Dose

Bacopa Monnieri (dose not specified)

Participants

52 healthy adults

Duration

28 days

Results

of a 28-day supplement intervention and 2-week follow-up study to assess changes in affect, cognition, cerebral haemodynamic response and BDNF in healthy middle-aged adults. The potential synergistic effects of polyphenolic compounds on neurocognitive function in middle-aged adults through emotional-cognitive processing and cognitive reserve are important for promoting brain and cognitive health.

How They Measured It

See study for outcome measures

Read full study
2

To investigate the effects of Bacopa Monnieri in evaluating the effects of bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: a triple-blinded, ran

2024 ? participants Duration not specified Bacopa Monnieri (dose not specified)
Human Study RCT Double-Blind Placebo Mixed

Study Type

Randomized, double-blind, placebo-controlled

Purpose

To investigate the effects of Bacopa Monnieri in evaluating the effects of bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment: a triple-blinded, ran

Dose

Bacopa Monnieri (dose not specified)

Participants

Participants not specified

Duration

Duration not specified

Results

Mild cognitive impairment is the middle level of natural cognitive impairment during primary steps of dementia. There are a few studies about improving the cognitive performance and sleep quality in patients with a limited dementia. So, this study was conducted to evaluate the effects of Bacopa monnieri on cognitive performance and sleep quality of patients with mild cognitive impairment.

How They Measured It

See study for outcome measures

Read full study
3

To investigate the effects of Bacopa Monnieri in bacopa monnieri in patients with parkinson's disease: a pilot study.

2023 ? participants 90 days Bacopa Monnieri (dose not specified)
Human Study RCT Double-Blind Placebo Mixed

Study Type

Randomized, double-blind, placebo-controlled

Purpose

To investigate the effects of Bacopa Monnieri in bacopa monnieri in patients with parkinson's disease: a pilot study.

Dose

Bacopa Monnieri (dose not specified)

Participants

Participants not specified

Duration

90 days

Results

with B. monnieri , and a moderate correlation for 60 and 90 days of treatment with B. monnieri when compared with baseline time. A moderate correlation was found between motor outcomes and Hoehn and Yahr stages at baseline. Our results suggest that B. monnieri extract can improve emotional function in Parkinson's disease patients, but further clinical trials are needed to confirm this possibility.

How They Measured It

See study for outcome measures

Read full study

Systematic reviews

1

To investigate the effects of Bacopa Monnieri in phytotherapy for attention deficit hyperactivity disorder (adhd): a systematic review and meta-analysis.

2022 ? participants Duration not specified Bacopa Monnieri (dose not specified)
Review/Other Positive

Study Type

Systematic review and meta-analysis

Purpose

To investigate the effects of Bacopa Monnieri in phytotherapy for attention deficit hyperactivity disorder (adhd): a systematic review and meta-analysis.

Dose

Bacopa Monnieri (dose not specified)

Participants

Participants not specified

Duration

Duration not specified

Results

nt of various symptoms of ADHD. Limited evidence was found for Ginkgo biloba L. and pine bark extract. However, various other preparations from other plants did not show significant efficacy. There is inadequate proof to strongly support and recommend the administration of herbal medicines for ADHD, but more research is needed in the relevant field to popularize the alternative treatment approach.

How They Measured It

See study for outcome measures

Read full study
2

To investigate the effects of Bacopa Monnieri in the effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized contr

2025 ? participants Duration not specified Bacopa Monnieri (dose not specified)
Review/Other Mixed

Study Type

Systematic review and meta-analysis

Purpose

To investigate the effects of Bacopa Monnieri in the effect of plant active substances on cognitive function in healthy older adults: a systematic review and network meta-analysis of randomized contr

Dose

Bacopa Monnieri (dose not specified)

Participants

Participants not specified

Duration

Duration not specified

Results

nt health concern for the older adults. The limited efficacy and common side effects of pharmacological interventions have made the exploration of safe non-pharmacological strategies an urgent need. Plant active substances have drawn much attention due to their multi-target neuroprotective properties, there is a lack of systematic comparative research on cognitive function in healthy older adults.

How They Measured It

See study for outcome measures

Read full study
3

To investigate the effects of Bacopa Monnieri in a systematic review of the safety and efficacy on cognitive function of herbal and nutritional medicines in older adults with and without subjective c

2023 ? participants Duration not specified Bacopa Monnieri (dose not specified)
Review/Other Mixed

Study Type

Systematic review

Purpose

To investigate the effects of Bacopa Monnieri in a systematic review of the safety and efficacy on cognitive function of herbal and nutritional medicines in older adults with and without subjective c

Dose

Bacopa Monnieri (dose not specified)

Participants

Participants not specified

Duration

Duration not specified

Results

CI and reduce dementia risk, and the popularity of herbal and nutritional medicines, the primary aim of this review was to investigate the efficacy on cognitive function and safety of herbal and nutritional medicines (relative to a control) for older adults with and without SCI. The secondary aims were to describe the study characteristics and assess the methodological quality of included studies.

How They Measured It

See study for outcome measures

Read full study

Frequently Asked Questions

Common questions about Bacopa Monnieri research

What does the research say about Bacopa Monnieri?

There are currently 15 peer-reviewed studies on Bacopa Monnieri (Bacopa monnieri), involving 360 total participants. Research covers Memory Enhancement (Healthy Adults), Cognitive Function in the Elderly & Anxiety Reduction, Meta-Analyses & Systematic Reviews and 4 more areas. The overall evidence strength is rated as Strong.

How strong is the evidence for Bacopa Monnieri?

The evidence is currently rated as "Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (10 human studies), and reported outcomes.

What health goals has Bacopa Monnieri been studied for?

Bacopa Monnieri has been researched for: Memory Enhancement (Healthy Adults), Cognitive Function in the Elderly & Anxiety Reduction, Meta-Analyses & Systematic Reviews, Memory & Cognition, ADHD & Attention, Clinical trials, Systematic reviews. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Bacopa Monnieri based on human trials?

Yes, 10 out of 15 studies are human trials. Human trials carry more weight in our evidence scoring system.